IL-33 deficiency slows cancer growth but does not protect against cisplatin-induced AKI in mice with cancer
Kameswaran Ravichandran(University of Colorado Denver), Charles L. Edelstein(University of Colorado Denver), Makoto Miyazaki(Chiba Cancer Center), Danica Galešić Ljubanović(University of Colorado Health), Chirag R. Parikh(College of Medicine & JNM Hospital), Raphael A. Nemenoff(University of Colorado Anschutz Medical Campus), Sara J. Holditch(University of Colorado Denver), Mary C.M. Weiser‐Evans(University of Colorado Anschutz Medical Campus), Carolyn Nicole Brown(University of Colorado Denver), Abdullah Özkök(University of Colorado Denver), Qian Wang(The Francis Crick Institute), Heather Thiessen‐Philbrook(Yale University)
Cited by 14
Related Papers
Loss of stearoyl–CoA desaturase-1 function protects mice against adiposity
|Proceedings of the National Academy of Sciences|2002|1.1k
Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US
|JAMA Internal Medicine|2020|1k
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
|The Lancet|2017|923
Role for Stearoyl-CoA Desaturase-1 in Leptin-Mediated Weight Loss
|Science|2002|833
Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19
|JAMA Internal Medicine|2020|555